Henry J. Fuchs - 13 Sep 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Reporting relationship
President, Worldwide R&D
Issuer ticker
BMRN
Reported as of
13 Sep 2024
Net transaction value
-$1,006,526
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Sep 2024, 17:54:07 UTC
Prior SEC filing
19 Mar 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Tae Sang Yoo, Attorney-in-Fact

Key filing fact

Henry J. Fuchs filed Form 4 for BIOMARIN PHARMACEUTICAL INC (BMRN) on 17 Sep 2024.

Key facts

  • This page summarizes Henry J. Fuchs's Form 4 filing for BIOMARIN PHARMACEUTICAL INC (BMRN).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Sep 2024, 17:54.

Change

  • Previous filing in this sequence was filed on 19 Mar 2024.
  • Current net transaction value: -$1,006,526.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BMRN transaction

Common Stock

Award

Transaction value
$20,594
Shares
+300
Change %
+0.15%
Price
$68.65
Shares after
197,172
Date
30 Apr 2024
Ownership
Direct
Footnotes
F1
BMRN transaction

Common Stock

Tax liability

Transaction value
$1,027,120
Shares
-12,098
Change %
-6.1%
Price
$84.90
Shares after
185,074
Date
13 Sep 2024
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .